MetLife, Inc.

New York Stock Exchange
Back to all articles
Neutral 0

MetLife (NYSE:MET) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

AI-generated analysis

📉 MetLife's Q1 CY2026 revenue grew 1.3% year-over-year to $19.07 billion, missing analyst estimates of $19.41 billion.

📊 Net premiums earned increased to $12.12 billion, beating expectations due to a lower-than-expected decline in core insurance business volume.

💰 Adjusted earnings per share reached $2.42, surpassing the consensus estimate of $2.27 by 6.6%.

🔻 Book value per share declined 7.1% year-over-year to $37.92, significantly below analyst estimates of $58.37.

💵 The company reported a pre-tax profit margin of 7.9% with total pre-tax profits of $1.51 billion.

🏢 MetLife continues to derive 69.1% of its revenue from core insurance underwriting over the last five years.

📈 Short-term growth has improved, with annualized revenue growth at 4.4% over the last two years compared to a sluggish 3.2% five-year average.

⚠️ The stock remained flat at $80.22 immediately following earnings due to mixed results on book value and revenue metrics.

🕰️ Founded in 1863, this New York-based financial services firm provides insurance, annuities, and asset management globally.

📉 Over the last five years, book value per share declined at a rate of 12.7% annually on a long-term basis.

🚀 Analysts project a massive 70.3% growth in book value per share over the next 12 months to reach $58.37.

📝 Management noted that certain quarters are outliers due to investment gains/losses and do not reflect recurring fundamentals.

🛑 The overall quarter was considered "softer" by analysts because revenue missed targets despite strong earnings per share performance.

🔍 Investors should evaluate MetLife in the context of longer-term business quality alongside current valuation metrics.

Bullish Signals
  • MetLife reported non-GAAP profit of $2.42 per share, which significantly beat analysts' consensus estimates by 6.6%.
  • Net premiums earned reached $12.12 billion, exceeding analyst estimates of $11.65 billion, driven by a resilient 4% year-on-year beat.
  • MetLife's two-year annualized revenue growth accelerated to 4.4%, which is above its five-year trend and shows recent improvement.
  • Over the next 12 months, consensus estimates project MetLife's Book Value per Share to grow by an elite 70.3% to $58.37.
  • MetLife's global financial services business has maintained a long history of providing insurance, annuities, and asset management since its founding in 1863.
Risk Factors
  • MetLife's Q1 CY2026 revenue of $19.07 billion missed Wall Street estimates by 1.7%, despite year-over-year growth only reaching a sluggish 1.3%.
  • Net premiums earned, which historically make up 69.1% of total revenue and serve as the most reliable metric for insurers, declined 4% year over year to $12.12 billion versus analyst expectations.
  • Book value per share dropped significantly by 35% compared to analyst estimates ($37.92 vs $58.37), indicating potential capital deterioration or valuation compression.
  • MetLife's five-year annualized revenue growth of 3.2% is described as sluggish and falls below the sector benchmark, raising concerns about its long-term growth baseline.
  • The company missed analyst consensus estimates for the key metric of Book Value per Share (BVPS), even though it beat estimates on EPS and Net Premiums Earned.
  • Despite beating profit estimates, the overall quarter was characterized as 'softer' due to the miss in top-line revenue and significant underperformance in BVPS relative to projections.
Full Analysis
MetLife (NYSE:MET) reported first-quarter fiscal year 2026 financial results that partially missed market expectations. The company posted revenue of $19.07 billion, representing a modest 1.3% year-over-year increase but falling short of the analyst estimate of $19.41 billion. While net premiums earned came in at $12.12 billion, exceeding the consensus of $11.65 billion by about 4%, and non-GAAP profit per share hit $2.42 against an expected $2.27, the report highlighted a significant miss in book value per share. This metric declined by 35% to $37.92, compared to analyst projections of $58.37, reflecting concerns about long-term capital growth relative to liability structures. The article provides historical context regarding MetLife's revenue trajectory, noting that the company has grown at an annualized rate of 3.2% over the last five years, which is described as sluggish relative to sector benchmarks. However, it highlights a more encouraging trend of 4.4% annualized growth over the last two years. The report emphasizes that net premiums earned constitute roughly 69% of MetLife's revenue, making it the most reliable and consistent source of income compared to investment fees or variable investment returns. Analysts note that while the stock traded flat at $80.22 following the earnings release, management views the current quarter as a single data point within a longer-term quality assessment framework. Beyond the immediate financial figures, the piece delves into the mechanics of insurance companies as balance sheet businesses where float—the premiums collected before claims are paid—is invested to generate investment income alongside premium revenue. The analysis suggests that Book Value Per Share (BVPS) is a critical metric for evaluating insurers because it captures the residual value of shareholders after accounting for both assets and liabilities, offering a view on long-term capital growth that is harder to manipulate than EPS. Despite the mixed quarter with missed revenue and book value targets, the analysts conclude that earnings performance should be evaluated in conjunction with valuation metrics to determine if MetLife represents a buy opportunity now, directing interested readers to their full research report for deeper actionable insights.